Meeting
2013 ASCO Annual Meeting
Concurrent chemoradiation (CChRT) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician Lung Cancer Group.
Authors
Joaquin Casal Rubio
Complexo Hospitalario Universitario de Vigo, Vigo, Spain
Joaquin Casal Rubio , EM Brozos , Martin Lázaro Quintela , Sergio Vazquez-Estevez , Jl Firvida , MB Taboada , M Caeiro , JE Castro , Maria Vieito Villar , Clara Senin Estor , MJ Villanueva , Silvia Varela Ferreiro , MC Areses , C Pena , P Calvo , E. Hernandez , N. Martinez , Urbano Anido , Gerardo Huidobro
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 7549)
DOI
10.1200/jco.2013.31.15_suppl.7549
Abstract #
7549
Poster Bd #
21C
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (TORG1018).
First Author: Kaoru Kubota
Poster
2015 ASCO Annual Meeting
A randomized phase II study of TS-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC): WJOG 5008L.
First Author: Takashi Seto
Poster
2012 ASCO Annual Meeting
SWOG S0533: A pilot trial of cisplatin (C)/etoposide (E)/radiotherapy (RT) followed by consolidation docetaxel (D) and bevacizumab (B) (NSC-704865) in three cohorts of patients (pts) with inoperable locally advanced stage III non-small cell lung cancer (NSCLC).
First Author: Antoinette J. Wozniak
Poster
2011 ASCO Annual Meeting
Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.
First Author: J. Zhang